| Record ID | marc_columbia/Columbia-extract-20221130-014.mrc:86773209:3726 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:86773209:3726?format=raw |
LEADER: 03726cam a22004694a 4500
001 6865480
005 20221122054235.0
008 080111t20082008nyu bf 001 0 eng
010 $a 2008001413
015 $aGBA817633$2bnb
016 7 $a101463368$2DNLM
016 7 $a014519324$2Uk
019 $a148750308
020 $a9780393705201 (hardcover)
020 $a039370520X (hardcover)
029 1 $aNLM$b101463368
035 $a(OCoLC)ocn190867382
035 $a(OCoLC)190867382$z(OCoLC)148750308
035 $a(NNC)6865480
035 $a6865480
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dBTCTA$dYDXCP$dC#P$dOrLoB-B
042 $apcc
050 00 $aRM315$b.M355 2008
060 10 $aQV 39$bM464p 2008
082 00 $a615/.788$222
100 1 $aMaxmen, Jerrold S.$0http://id.loc.gov/authorities/names/n80090259
245 10 $aPsychotropic drugs :$bfast facts /$cJerrold S. Maxmen, Sidney H. Kennedy, Roger S. McIntyre.
250 $a4th ed.
260 $aNew York :$bW.W. Norton & Co.,$c[2008], ©2008.
300 $axxii, 260 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $g1.$tAntipsychotics -- $tIntroduction to Drug Class -- $tFirst-Generation Antipsychotics -- $tSecond-Generation Antipsychotics -- $tTherapeutic Application -- $g2.$tAgents for Treating Movement Disorders -- $tIntroduction to Drug Class -- $g3.$tAntidepressants -- $tIntroduction to Drug Class -- $tMonoamine Oxidase Inhibitors -- $tTransporter Inhibitors -- $tReceptor Antagonists/Agonists -- $tTherapeutic Application -- $g4.$tDementia-Treating Agents -- $tIntroduction to Drug Class -- $tCholinesterase Inhibitors -- $tNMDA Antagonist -- $tTherapeutic Application -- $g5.$tMood Stabilizers -- $tIntroduction to Drug Class -- $tLithium -- $tAnticonvulsants -- $tTherapeutic Application -- $g6.$tAntianxiety Agents -- $tIntroduction to Drug Class -- $tBenzodiazepines -- $tNonbenzodiazepines -- $tTherapeutic Application -- $g7.$tHypnotics -- $tIntroduction to Drug Classes -- $tHypnotic Benzodiazepines and Selective Benzodiazepine-1 Receptor Agonists -- $tSelective Melatonin Agonist -- $tBarbiturates and Barbiturate-Like Compounds -- $tAdditional Sleep-Promoting Agents -- $tTherapeutic Application -- $g8.$tStimulants and Stimulant-Like Agents -- $tIntroduction to Drug Class -- $tFirst-Generation Stimulants -- $tSecond-Generation Stimulants -- $tTherapeutic Application -- $g1.$tDrug Identification by Generic Name -- $g2.$tDrug Identification by Trade Name -- $g3.$tDrug Interactions - Cytochrome P450 Enzymes -- $g4.$tMeasurement-Based Care.
500 $a"A Norton professional book"--P. facing t.p.
504 $aIncludes bibliographical references (p. 235-242) and index.
520 1 $a"Now in its fourth edition - updated to reflect the latest research and emerging treatments - Psychotropic Drugs: Fast Facts continues to present valuable information in a clear, accessible format. Organized by major drug classes, it offers comprehensive data on dosage, side effects, drug-drug interactions, withdrawal, and more - everything mental health clinicians need to know to properly manage their clients' pharmacological treatment. This is an all-in-one drug resource guide you won't want to be without."--BOOK JACKET.
650 0 $aPsychotropic drugs$vHandbooks, manuals, etc.$0http://id.loc.gov/authorities/subjects/sh2008110169
650 12 $aPsychotropic Drugs.$0https://id.nlm.nih.gov/mesh/D011619
655 2 $aHandbook.$0https://id.nlm.nih.gov/mesh/D020479
700 1 $aKennedy, Sidney H.$0http://id.loc.gov/authorities/names/n89143377
700 1 $aMcIntyre, Roger S.$0http://id.loc.gov/authorities/names/no2002037534
852 00 $boff,hsl$hRM315$i.M355 2008